PamGene

Netherlands
's-Hertogenbosch, North Brabant, The Netherlands

Company profile

PamGene company profile

PamGene has a unique proprietary array-based platform to measure the activities of kinases & nuclear receptors, enabling deeper understanding of drug interactions with these important classes of signalling molecules. PamGene's patented technology finds a wide range of applications including lead identification and optimization, (pre) clinical translational research and biomarker development.

Business identity

Contact email
[email protected]
Phone number
+310736158080
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2000-01-01, Year

Headquarters

Country code
NL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$17.5M
Last funding
Grant / $1.1M / 2023-01-17
Last equity funding
Series B / $11.3M
Investors
5
Lead investors
2
Articles
2

Founders and investors

Lead investors

EurostarsLCF Rothschild

Investors

Alta PartnersEQT Life SciencesEurostarsGimvLCF Rothschild